Lv4
740 积分 2021-08-18 加入
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
1天前
已完结
[Chinese guidelines for diagnosis and treatment of chronic rhinosinusitis (2018)]
9天前
已完结
Current research on pathogenesis and treatment of atopic dermatitis
9天前
已完结
Modulation of the high concentration viscosity of IgG 1 antibodies using clinically validated Fc mutations
15天前
已完结
Oncolytic virus VG161 in refractory hepatocellular carcinoma
17天前
已完结
Safety Concerns Prompt Pause of Magrolimab Trials
1个月前
已完结
A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell–Mediated Immune Response against EGFR-Expressing Tumors
1个月前
已完结
Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study
1个月前
已完结
Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis
1个月前
已完结
Calreticulin P-domain-derived “Eat-me” peptides for enhancing liposomal uptake in dendritic cells
2个月前
已完结
皖公网安备34019202002308
